In this part two of the three-part series, we continue to explore the evolving funding landscape for medtech companies. Over the past three years, access to capital has become more challenging, pushing startups to adopt innovative commercialization strategies. Our guests, including experts from Hatch Medical and PavMed, discuss the importance of forming strategic partnerships with midsize companies to navigate regulatory hurdles and leverage economies of scale.
The episode also examines how startups can attract investors by demonstrating value and achieving critical milestones. By focusing on accretive value and understanding the funding environment, startups can position themselves as attractive targets for acquisition by larger companies. Our conversation highlights the importance of nailing down supply chain management, regulatory pathways, and reimbursement processes to ease investor concerns.
Additionally, we discuss the impact of AI and emerging technologies in the MedTech space. AI offers transformative potential but also presents regulatory challenges that require careful navigation. Our guests, including Dr. Acklon and Todd, emphasize the need for clear application and robust data management practices.
________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.